Clinical Trial Update: Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of BIO-11006 inhalation solution in adults with respiratory distress syndrome (ARDS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Adult

Drugs mentioned

• BIO-11006

Snippet

Sponsor: BioMarck Pharmaceuticals, Ltd. | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED